CSCIF
COSCIENS Biopharma Inc. OTC$1.96
Mkt Cap $6.2M
52w Low $0.79
32.4% of range
52w High $4.40
50d MA $1.66
200d MA $2.34
P/E (TTM)
-0.6x
EV/EBITDA
-0.1x
P/B
1.6x
Debt/Equity
0.6x
ROE
-158.4%
P/FCF
-0.7x
RSI (14)
—
ATR (14)
—
Beta
1.45
50d MA
$1.66
200d MA
$2.34
Avg Volume
3.3K
About
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reductio…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | AMC | -3.48 | -0.69 | +80.2% | 0.84 | +18.2% | -1.4% | -0.9% | +25.3% | +21.7% | +37.3% | — |
| Nov 11, 2025 | AMC | — | -0.57 | — | 2.45 | -1.2% | -6.1% | -5.3% | -8.6% | -16.3% | -13.9% | — |
| Aug 14, 2025 | AMC | — | -0.85 | — | 3.50 | -11.4% | -18.6% | -17.4% | -24.9% | -20.6% | -22.9% | — |
| Apr 9, 2025 | AMC | -3.48 | -2.15 | +38.2% | 2.82 | +1.1% | -0.4% | +1.1% | +3.2% | +0.7% | +0.0% | — |
| Mar 28, 2025 | AMC | — | -4.64 | — | 3.04 | +2.0% | -7.2% | -5.6% | -3.3% | -10.5% | -15.8% | — |
| Nov 12, 2024 | AMC | -3.48 | -1.85 | +46.8% | 3.00 | +1.3% | +8.3% | +4.7% | +7.7% | +6.7% | +0.0% | — |
| Aug 13, 2024 | AMC | -3.28 | -0.64 | +80.5% | 6.42 | +0.6% | +1.2% | -6.4% | -12.0% | -10.7% | -8.6% | — |
| May 14, 2024 | AMC | -3.24 | -4.74 | -46.3% | 8.39 | +1.8% | +3.1% | +2.4% | +1.5% | +1.9% | -0.2% | — |
| Mar 27, 2024 | AMC | -0.97 | -1.16 | -19.6% | 8.32 | -1.4% | +5.3% | +0.5% | +1.4% | +1.0% | +0.0% | — |
| Nov 9, 2023 | AMC | -2.44 | -3.40 | -39.3% | 6.16 | -2.6% | -5.8% | -3.9% | -0.6% | -3.2% | +4.5% | — |
Data updated apr 27, 2026 11:04pm
· Source: massive.com